May 22, 2007 — The U.S. ultrasound market, accounting for about 30 percent of the worldwide market, hit a record $1.33 billion in 2006, according to a report just published by Klein Biomedical Consultants Inc. (KBC), the industry's leading consultants in the field. Although product revenues rose a respectable 5.3 percent, a 23 percent drop in upgrades reduced the overall market growth to only 2.6 percent. The cardiology ultrasound market segment surpassed total radiology ultrasound revenues including upgrades for the first time in 2006.

May 22, 2007 — A widely used diabetes pill raises the risk of heart attacks and possibly death, according to a scientific analysis that reveals what some experts are calling another Vioxx-like example of the government failing to protect the public from an unsafe drug.

More than 6 million people worldwide have taken the drug, sold as Avandia and Avandamet, since it came on the market eight years ago to help control blood sugar in people with the most common form of diabetes. About 1 million Americans use it now.

May 22, 2007 - GE Healthcare today announced an important leadership change for one of the largest businesses within the company. Jim Davis has been promoted to the position of Vice President and General Manager of the company's Global Magnetic Resonance (MR) business. Davis replaces John Chiminski, who is now leading the integration of GE Healthcare’s acquisition of Abbott’s primary in vitro diagnostics businesses and Abbott Point-of-Care diagnostics businesses. Chiminski will lead GE’s new Clinical Diagnostics business following the closing of the acquisition.

May 22, 2007 - The Moores Cancer Center at the University of California, San Diego (UCSD) recently announced it is the first facility in California and the second in the nation to offer SAVI, a single-entry, multi-catheter applicator that delivers partial breast irradiation, offering advanced treatment for breast cancer as part of breast conservation therapy.